Introduction {#s1}
============

Mammalian postnatal growth is regulated primarily by the growth hormone (GH)/insulin-like growth factor I (IGF-I) axis \[[@r20]\]. GH is secreted from somatotrophic cells in the anterior pituitary glands in a pulsatile manner regulated by hypothalamic growth hormone-releasing hormone (GHRH). In addition, GH secretion is enhanced by ghrelin and inhibited by somatostatin. GH induces hepatic IGF-I secretion that plays a crucial role in promoting linear skeletal growth during childhood \[[@r31]\]. In addition to regulation by GH, circulating IGF-I is affected by nutritional status, namely, low energy intake or protein deficiency that can suppress hepatic IGF-I secretion \[[@r6], [@r12]\]. Additionally, proteolytic enzymes attack certain conformations of circulating IGF-I, as evidenced by the lower half-life (a few minutes) of free IGF-I versus the stabilized complex (more than 10 h) that contains IGF binding protein 3 (IGFBP3) \[[@r1]\] and the acid-labile subunit (ALS) \[[@r29]\].

MafB is a basic leucine zipper (bZip) transcription factor that belongs to the large Maf family, whose proteins commonly bind to a consensus DNA sequence referred to as the Maf recognition element (MARE) \[[@r5]\]. MafB plays a crucial role in fetal development of several organs such as the kidneys \[[@r21]\], inner ear \[[@r4]\], pancreatic islets \[[@r8]\], and parathyroid glands \[[@r15]\]. MafB also plays a role in maintenance of adult tissues through transcription of key molecules such as glucagon \[[@r16]\], parathyroid hormone \[[@r23]\], nephrin, and podocin \[[@r22], [@r27]\].

MafB is diffusely expressed in the developing brain \[[@r3], [@r19]\]. Earlier studies using *Kreisler* mice carrying *Mafb* mutations have revealed that it guides hindbrain segmentation in the early embryonic stage \[[@r4]\]. MafB is also essential for development of the pre-Bötzinger complex in the medulla oblongata, which is responsible for respiratory rhythmogenesis \[[@r2]\]. However, the postnatal role of MafB in neurons remains to be elucidated.

Here, we have generated neuron-specific *Mafb* conditional knockout (cKO) mice. Approximately half of the *Mafb* cKO mice died within 48 h after birth, and the survivors exhibited growth retardation. There was no evidence of low energy intake in these mice, but GH/IGF-I axis impairment was observed. Our study reveals that the function of MafB in neurons is important for postnatal growth regulated by the GH/IGF-I axis.

Materials and Methods {#s2}
=====================

Mice
----

*Mafb^flox^*^/^*^flox^* mice in which *loxP* sites flank exon 1 of the *Mafb* gene \[[@r28]\], *Mafb*-deficient (*Mafb^−/−^*) mice in which the GFP gene is knocked-in in the *Mafb* locus \[[@r21]\], and R26GRR mice in which a switch of constitutive expression from GFP to tdsRed is induced by Cre-mediated recombination in the ROSA locus \[[@r11]\] were described previously. Nes-Cre mice, neuron-specific Cre driver mice \[[@r13]\], were kindly provided from by R. Kageyama (Kyoto University). All mice were maintained on the C57BL/6J background. The pups were weaned at 3 weeks of age. All experiments were performed according to the Guide for the Care and Use of Laboratory Animals at the University of Tsukuba.

Brain sections and immunohistochemistry
---------------------------------------

Mice at embryonic day 12.5 (E12.5) and postnatal day 0 (P0) were fixed with paraformaldehyde (PFA) in PBS at 4°C overnight. Next, whole embryos and brains at P0 were cryoprotected in 30% sucrose and embedded in Tissue-Tek OCT compound (Sakura Finetek, Tokyo, Japan). Frozen sections were prepared at a thickness of 20 *µ*m using a cryostat. For immunohistochemistry, sections were blocked with 10% normal goat serum plus 0.3% Triton X-100 in PBS for 1 h at room temperature. The sections were incubated with anti-MafB antibody (1:500, IHC-00351, Bethyl Laboratories, Montgomery, TX, USA) overnight at 4°C. After washing, slides were incubated with Alexa Fluor 594-conjugated secondary antibody (Molecular Probes, Eugene, OR, USA) for 1 h at room temperature. Fluorescent images were acquired using a Biorevo BZ-9000 fluorescence microscope (Keyence, Osaka, Japan). For assessment of efficiency of Cre-mediated recombination, 4 sections were prepared from each sample, and tdsRed-positive areas were measured with ImageJ software (NIH, Bethesda, MD, USA).

Measurements of blood glucose and serum IGF-I
---------------------------------------------

Blood was collected by cardiac puncture, and glucose concentration was immediately measured with a Medisafe glucometer (Terumo, Tokyo, Japan). After clotting, blood was centrifuged at 3,000 g for 10 min, and the resultant supernatant was collected. Serum IGF-I concentration was measured with a Mouse/Rat IGF-I Quantikine ELISA kit (MG100, R&D systems, Minneapolis, MN, USA).

GHRH administration and GH measurement
--------------------------------------

Mice at 4 weeks of age were injected intraperitoneally with 5 *µ*g of human GHRH (GHRH-288H, Creative Biomart, Shirley, NY, USA). Blood was repeatedly collected through a facial vein before and 5 min after GHRH administration. To minimize the effect of diurnal variation of GH, the experiments were performed between 9 a.m. and 11 a.m. Serum GH concentration was measured with a Rat/Mouse GH ELISA (EZRHGH-45K, MilliporeSigma, Burlington, MA, USA).

Quantitative RT-PCR
-------------------

Total RNA was extracted from snap-frozen livers at P14 with Isogen (Nippon Gene, Tokyo, Japan), and cDNA was synthesized with a QuantiTect Reverse Transcription kit (QIAGEN, Hilden, Germany), each according to manufacturers' instructions. Real-time PCR was run on a Thermal Cycler Dice Real Time System Single (Takara, Shiga, Japan) with SYBR Green PCR master mix (Takara). The primer sequences used were as follows: *Pck1* forward, 5'-CACCATCACCTCCTGGAAGA-3'; *Pck1* reverse, 5'-GGGTGCAGAATCTCGAGTTG-3'; *G6pc* forward, 5'-CGACTCGCTATCTCCAAGTGA-3'; *G6pc* reverse, 5'-GTTGAACCAGTCTCCGACCA-3'; *Fgf21* forward, 5'-GTGTCAAAGCCTCTA­GGTTTCTT-3'; *Fgf21* reverse, 5'-GGTACACATTGT­AACCGTCCTC-3'; *Hprt* forward, 5'-TTGTTGTTGGATATGCCCTTGACTA-3'; *Hprt* reverse, 5'-AGGCAGATGGCCACAGGACTA-3'. All PCR was performed duplicates in all cases, and amplification products were quantified by the standard curve method. The mRNA levels of each gene were normalized to *Hprt*.

Statistical analysis
--------------------

Data are expressed as means ± SEMs. Differences between the two groups were analyzed using a Student *t*-test or a Wilcoxon rank-sum test. For intraindividual comparison, a paired *t*-test was applied. For comparison of survival rate, a Fisher exact test was applied. For multiple comparisons, a Tukey honest significant differences (HSD) test or a Bonferroni correction was applied. All statistical analyses were performed with R software (http://www.r-project.org). Probability values of less than 0.05 were considered significant.

Results {#s3}
=======

Neuron-specific deletion of the Mafb gene causes neonatal death
---------------------------------------------------------------

To delete the *Mafb* gene specifically in the neural lineage using a Cre-*loxP* strategy, we chose a line of Nes-Cre mice \[[@r13]\]. Given that spatiotemporal validity of Nes-Cre mice has been argued \[[@r14], [@r17]\], we initially evaluated the recombination efficiency of the Nes-Cre mice by crossing with GRR26R mice, reporter mice in which cells are labeled with tdsRed by Cre-mediated recombination \[[@r11]\] (Nes-Cre;R26GRR mice). We found that recombination-induced tdsRed expression is incomplete in the brains at E12.5, particularly in the cerebral cortex and tectum of the midbrain ([Fig. 1A](#fig_001){ref-type="fig"}Fig. 1.Neuron-specific deletion of *Mafb* gene causes neonatal death. Parasagittal images of the Nes-Cre;R26GRR brains at E12.5 (A) and P0 (B) and of the *Mafb^GFP^*^/+^ brain at E12.5 (C). (A, B) tdsRed (red) and GFP (green) indicate areas with and without Cre-mediated recombination, respectively. Te, telencephalon; De, diencephalon; MB, midbrain; HB, hindbrain. Scale bars: 1 mm. (C) The GFP signals, which recapitulate endogenous MafB expression, are obviously observed in the hindbrain (arrow) and the hindbrain choroid plexus (hChP). Scale bar: 1 mm. (D) Percentage of tdsRed-positive areas in the different brain regions of the Nes-Cre;R26GRR mice at E12.5 and P0. n=3 per group. (E) Immunohistochemical staining of MafB in the cerebral cortices at P0. MafB immunoreactivity (red) is absent in the "MafB-positive" neurons (green) of Nes-Cre;*Mafb^flox^*^/^*^GFP^* pups (lower panel). Scale bar: 100 *µ*m. (F) Neonatal outcome at 48 h after birth. \*\*\**P*\<0.001, Fisher exact test.). At P0, tdsRed-positive areas covered more than 90% of the brain parenchyma of the Nes-Cre;R26GRR mice ([Fig. 1B, D](#fig_001){ref-type="fig"}). We also analyzed MafB expression using *Mafb^GFP^*^/+^ mice \[[@r21]\] and confirmed that MafB is already expressed in the hindbrain at E12.5 ([Fig. 1C](#fig_001){ref-type="fig"}). These results imply that residual activity of MafB in embryonic neurons may have some effects on the phenotype of the *Mafb* cKO mice.

Next, we generated neuron-specific *Mafb* cKO mice by crossing the Nes-Cre mice with *Mafb^flox^*^/^*^flox^* mice \[[@r28]\] (Nes-Cre;*Mafb^flox^*^/^*^flox^* mice). Furthermore, we performed immunohistochemistry for MafB using Nes-Cre;*Mafb^flox^*/*GFP* mice and confirmed successful deletion of MafB protein in GFP-positive ("MafB-positive") cortical neurons at P0 ([Fig. 1E](#fig_001){ref-type="fig"}).

Whole-body deletion of the *Mafb* gene leads to 100% neonatal death due to respiratory arrest associated with abnormalities in fetal brain development \[[@r2]\]. Within 48 h after birth, 48% (12 out of 25) of the *Mafb* cKO mice pups died, which is far higher compared with the 4% (1 out of 26) of the *Mafb^flox^*^/^*^flox^* pups ([Fig. 1F](#fig_001){ref-type="fig"}). This result reinforces the idea that MafB plays an important role in neural development that facilitates perinatal survival.

Neuron-specific Mafb cKO mice exhibit growth retardation
--------------------------------------------------------

We monitored postnatal growth of the surviving *Mafb* cKO mice. On the day of birth, no significant difference in body weight was observed between the *Mafb* cKO and two control (Nes-Cre;*Mafb^flox^*^/+^ and *Mafb^flox^*^/^*^flox^*) mice ([Fig. 2A](#fig_002){ref-type="fig"}Fig. 2.Neuron-specific *Mafb* cKO mice exhibit growth retardation. (A) Body weight during the postnatal stage in each genotype. n=5--15 per group. \*\**P*\<0.01, Tukey honest significant differences (HSD) test. \*\*\**P*\<0.001, Tukey HSD test. N.S., not significant. (B) P7 pups of *Mafb^flox^*^/^*^flox^* (left) and Nes-Cre;*Mafb^flox^*^/^*^flox^* (right). (C) Growth curves after weaning of male (left) and female (right) mice. n=10--15 per group. (D) Differences in body weight between genotypes at 12 weeks of age. \**P*\<0.05, Tukey HSD test. \*\**P*\<0.01, Tukey HSD test.). At the postnatal stage, however, weight gain in *Mafb* cKO mice was stunted compared with the control mice ([Figs. 2](#fig_002){ref-type="fig"}A and B). After weaning, the *Mafb* cKO mice started to catch up with the control mice ([Fig. 2C](#fig_002){ref-type="fig"}), resulting in a marginal difference in body weight among genotypes at 12 weeks of age ([Fig. 2D](#fig_002){ref-type="fig"}).

Neuron-specific Mafb cKO mice exhibit no signs of low energy intake in the postnatal stage
------------------------------------------------------------------------------------------

Since low energy intake as a result of poor suckling could be a cause of growth retardation, we investigated the nutritional status of Nes-Cre;*Mafb^flox^*^/^*^flox^* mice. Blood glucose levels in the *Mafb* cKO mice were comparable to those of *Mafb^flox^*^/^*^flox^* mice ([Fig. 3A](#fig_003){ref-type="fig"}Fig. 3.Neuron-specific *Mafb* cKO mice exhibit no signs of low energy intake in the postnatal stage. (A) Blood glucose levels at P14. n=11 (*Mafb^flox^*^/^*^flox^*) and 9 (Nes-Cre;*Mafb^flox^*^/^*^flox^*). Red lines represent means ± SEMs. No significant difference is found between genotypes (Student *t*-test). (B) Quantitative RT-PCR analysis does not show upregulation of gluconeogenesis-related genes (*Pck1, G6pc, Fgf21*) in the livers of Nes-Cre;*Mafb^flox^*^/^*^flox^* mice at P14 (Student *t*-test). n=4 per group.). To further test the possibility that activated gluconeogenesis compensates for low energy intake \[[@r18]\], we examined expression levels of gluconeogenesis-related genes (*Pck1, G6pc,* and *Fgf21*) in the liver. The qRT-PCR experiments did not show any significant differences in these genes. ([Fig. 3B](#fig_003){ref-type="fig"}). According to these results, the *Mafb* cKO mice exhibited no signs of low energy intake.

The GH/IGF-I axis is impaired in neuron-specific Mafb cKO mice
--------------------------------------------------------------

To identify the cause of growth retardation in the *Mafb* cKO mice, we measured circulating levels of GH and IGF-I that critically regulate body size \[[@r31]\]. Notably, serum IGF-I levels in the *Mafb* cKO mice were significantly lower than those in the *Mafb^flox^*^/^*^flox^* mice ([Fig. 4A](#fig_004){ref-type="fig"}Fig. 4.The growth hormone (GH)/insulin-like growth factor I (IGF-I) axis is impaired in neuron-specific *Mafb* cKO mice. (A) Serum IGF-I levels at 4 weeks of age. n=10 per group. \*\*\**P*\<0.001, Student *t*-test. (B) Serum GH levels before and 5 min after intraperitoneal administration of growth hormone-releasing hormone (GHRH) (5 *µ*g) at 4 weeks of age. n=8 (*Mafb^flox^*^/^*^flox^*) and 9 (Nes-Cre;*Mafb^flox^*^/^*^flox^*). \**P*\<0.05, paired *t*-test (0 min vs. 5 min) or Wilcoxon rank sum test (*Mafb^flox^*^/^*^flox^* vs. Nes-Cre;*Mafb^flox^*^/^*^flox^*) adjusted by Bonferroni correction. N.S., not significant. Red lines represent means ± SEMs.). We further investigated GH secretory capacity from the anterior pituitary gland in response to GHRH administration and found that, in the basal state, serum GH levels in the *Mafb* cKO mice were significantly higher than those in *Mafb^flox^*^/^*^flox^* mice. Upon administration of GHRH, *Mafb^flox^*^/^*^flox^* mice consistently exhibited enhanced GH secretion while the *Mafb* cKO mice had an inconsistent response to GHRH ([Fig. 4B](#fig_004){ref-type="fig"}).

Discussion {#s4}
==========

In the present study, we generated and analyzed neuron-specific *Mafb* cKO mice. We found that half of these mice die within 48 h after birth and that the surviving pups exhibit stunted growth. Analysis of blood glucose and gene expression related to gluconeogenesis did not indicate any low energy intake; however, serum IGF-I levels of the *Mafb* cKO mice were lower than those of control mice. Conversely, we found that serum GH levels (upstream of IGF-I) were upregulated at rest in the *Mafb* cKO mice but that GHRH-induced GH secretion in these mice was inconsistent. Collectively, our findings reveal that neuronal MafB plays an important role in postnatal development.

Whole-body deletion of *Mafb* gene causes 100% neonatal death by respiratory arrest, which may be attributed to abnormal development of the pre-Bötzinger complex in the medulla oblongata \[[@r2]\]. In our study, the neonatal mortality rate of the *Mafb* cKO pups was approximately 50%. Although we did not examine the respiratory activity of these mice, it is likely that their respiratory rhythmogenesis after birth is impaired due to lack of neuronal MafB. Given the results of our histological analysis using Nes-Cre;R26GRR mice, the reduction of mortality rate may be attributed to incomplete deletion of neuronal MafB in the early embryonic stage. Our results do reinforce the idea that MafB in the developing neurons plays a critical role in preparing neonates for adaptation to the postnatal environment.

Although the surviving *Mafb* cKO pups exhibit growth retardation, it should be noted that a Nes-Cre transgene per se may cause problems with the growth of transgenic mice. In fact, the Nes-Cre mouse line from the Jackson Laboratory (No. 003771, https://www.jax.org/strain/003771) has metabolic and endocrine phenotypes including lower production of anterior pituitary hormones such as GH and thyroid stimulating hormone (TSH) \[[@r7], [@r9]\]. In our study, Nes-Cre;*Mafb^flox^*^/+^ mice were comparable in body weight to *Mafb^flox^*^/^*^flox^* mice, and moreover, the *Mafb* cKO mice were significantly smaller than either of these two mice. Therefore, it is safe to say that this Nes-Cre transgene \[[@r13]\] does not account for the growth retardation of the *Mafb* cKO mice.

To probe the phenotype of *Mafb* cKO mice, we analyzed nutritional status, as it is critical for postnatal growth, and abnormal brain development is often accompanied by poor suckling \[[@r26]\]. Although ingested milk amounts are quite difficult to measure, activation of gluconeogenesis can serve as a biomarker for low energy intake \[[@r18]\]. However, gluconeogenesis upregulation was not observed in our study.

Given that the GH/IGF-I axis is critical for postnatal growth \[[@r31]\], reduction of circulating IGF-I is most likely a cause of growth retardation in the *Mafb* cKO mice. We also found that basal GH levels are elevated in the *Mafb* cKO mice, which is probably due to attenuated negative feedback from IGF-I to somatotrophic cells in the pituitary \[[@r6]\]. In addition to indirect effects via IGF-I, GH has a direct effect on promoting longitudinal skeletal growth independently of IGF-I \[[@r30]\]. Thus, upregulation of basal GH levels may contribute to the growth of the *Mafb* cKO mice catching up after weaning. Furthermore, inconsistent GH secretion in response to GHRH, which is indicative of neuroendocrine dysregulation, was observed in the *Mafb* cKO mice. However, it remains unknown how neuron-specific *Mafb* deletion results in the reduction of circulating IGF-I. Region- or cell-type-specific Cre drivers \[[@r10]\] would be helpful in solving this remaining issue.

*MAFB* mutations in humans cause either multicentric carpotarsal osteolysis (MCTO \[MIM 166300\]) \[[@r24], [@r32]\] or a subset of Duane retraction syndrome (DRS \[MIM 126800\]) \[[@r25], [@r27]\] depending on the affected site. MCTO is characterized by childhood-onset arthritis, and DRS is characterized by congenital disorders of outward eye movement; both diseases are often accompanied by progressive nephropathy leading to end-stage renal disease. Unfortunately, neither postnatal skeletal growth nor blood concentrations of GH or IGF-I have been described in previous reports of these *MAFB* mutation-mediated diseases. Our results may therefore be an important first look at hidden dysregulation in the GH/IGF-I axis within *MAFB*-mediated diseases.

In summary, our study using neuron-specific *Mafb* cKO mice revealed that MafB in neurons plays an important role for postnatal growth regulated by the GH/IGF-I axis.
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